TALTZ
Drug timelines are a Plus or Pro feature.
25 regulatory and trial events tracked for TALTZ, covering 2016-03-22 to 2026-08-21. Get the full timeline:
Most recent: EMA Authorised: Taltz (ixekizumab) — Eli Lilly and Company (Ireland) Limited